Health Technology · Pharmaceuticals: Other · NSE: SATKARTAR · data 2026-10-09

Sat Kartar Life Limited

Health check: Strong (8.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹136.6

Market cap

₹227 cr

P/E

12.6

P/B

—

ROE

28.7%

ROCE

34.8%

Debt / equity

0.04

Dividend yield

0.49%

1-year return

-11.3%

52-week high

₹219.8

52-week low

₹110.3

Operating margin

10.6%

Growth

Revenue (last 12 months)	₹201 cr
Net profit (last 12 months)	₹17 cr
Sales growth, 3 years (yearly)	34.2%
Profit growth, 3 years (yearly)	89.7%

Similar companies

Amrutanjan Health Care Limited (AMRUTANJAN) · Shri Ahimsa Naturals Limited (SHRIAHIMSA) · Influx Healthtech Limited (INFLUX) · Lyka Labs Limited (LYKALABS) · Natural Capsules Limited (NATCAPSUQ)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SATKARTAR in NSE Scanner →